Dual-function regulator MexL as a target to control phenazines production and pathogenesis of Pseudomonas aeruginosa

Zhaoxiao Yu1,2, Zhikun Wu3,4, Dejian Liu1,2

  • 1State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Nature Communications
|February 26, 2025
PubMed

Insights

Scientists identified MexL as a key regulator of Pseudomonas aeruginosa virulence. Targeting MexL with new antimicrobials reduces pathogen virulence and enhances antibiotic effectiveness against infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Antibiotic resistance poses a global health crisis, necessitating novel therapeutic strategies.
  • Pseudomonas aeruginosa is an opportunistic pathogen whose virulence is linked to factors like phenazine pyocyanin (PYO).
  • Identifying new drug targets is crucial for effective infection control.

Purpose of the Study:

  • To investigate the role of the multidrug efflux pump repressor, MexL, in regulating phenazine production and virulence in Pseudomonas aeruginosa.
  • To identify potential antimicrobial compounds that target MexL to control P. aeruginosa infections.

Main Methods:

  • Investigated MexL's function as a transcriptional activator binding to phenazine biosynthesis gene promoters.
  • Utilized structural analysis of MexL to identify potential drug interactions.
  • Conducted in vivo studies to evaluate the efficacy of MexL-targeting antimicrobials in combination with existing antibiotics.

Main Results:

  • MexL acts as a transcriptional activator, enhancing phenazine pyocyanin (PYO) production by binding to conserved DNA motifs.
  • PYO negatively regulates its own production by acting as a ligand for MexL.
  • MexL knockout significantly reduces P. aeruginosa virulence and antibiotic tolerance.
  • Two novel antimicrobials were identified that interact with MexL, decreasing PYO production and virulence.

Conclusions:

  • MexL is a critical regulator of P. aeruginosa virulence and phenazine production.
  • Targeting MexL with specific antagonists offers a promising strategy to combat P. aeruginosa infections.
  • Combining MexL-antagonists with conventional antibiotics may enhance treatment efficacy and overcome antibiotic resistance.